HomeCommentary

Commentary

Epigenetic Drug Discovery Efforts Expanding, with Solid Cancers Now Being Targeted
(Sep.1.2017)

By Shinya Sato

Targets for epigenetic drug discovery are now expanding beyond the field of hematologic cancer. Drug makers worldwide are starting to develop epigenetic drugs for solid tumors as well. In the future, development could expand to include diseases other than cancer such as diabetes and Alzheimer’s disease ...

(LOG IN FOR FULL STORY)

News Calendar